These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1237421

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH, Mahler RF, Hales CN.
    Lancet; 1976 Feb 28; 1(7957):444-7. PubMed ID: 55717
    [Abstract] [Full Text] [Related]

  • 43. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S, Koniçe M, Sencer E, Molvalìlar S, Alp H.
    Isr J Med Sci; 1972 Jun 28; 8(6):815-20. PubMed ID: 5051802
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Insulin in portal, hepatic and peripheral venous blood after glucose, tolbutamide and glipizide stimulation. Indication of insulin release from peripheral tissues.
    Hed R, Nygren A, Röjdmark R, Sundblad L, Wiechel KL.
    Acta Med Scand; 1979 Jun 28; 205(3):221-5. PubMed ID: 371340
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
    Ogura C.
    Hokkaido Igaku Zasshi; 1975 Sep 28; 50(5):489-506. PubMed ID: 815150
    [Abstract] [Full Text] [Related]

  • 49. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P, Souvatzoglou A, Schwarz K, Rettig M.
    Verh Dtsch Ges Inn Med; 1971 Sep 28; 77():556-9. PubMed ID: 5155896
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E, Slabochová Z, Platilová H, Pavlik F, Grafnetterová J, Dvorácek K.
    Int J Clin Pharmacol Biopharm; 1977 Jan 28; 15(1):7-12. PubMed ID: 838527
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
    Lewis GF, Vranic M, Giacca A.
    Am J Physiol; 1998 Jul 28; 275(1):E177-86. PubMed ID: 9688888
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Studies on the bio-availability of tolbutamide (author's transl)].
    Rupp W, Dibbern HW, Hajdu P, Ross G, Vander Elst E.
    Dtsch Med Wochenschr; 1975 Mar 28; 100(13):690-5. PubMed ID: 1091434
    [Abstract] [Full Text] [Related]

  • 60. Influence of diftalone on tolbutamide test and i.v. glucose tolerance test.
    Scherak O, Weissel M, Fritzsche H, Kolarz G.
    Int J Clin Pharmacol Biopharm; 1976 Sep 28; 14(2):86-92. PubMed ID: 1087282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.